MCF Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-560
Closed -$34.8K 1038
2023
Q4
$34.8K Sell
560
-76
-12% -$4.25K ﹤0.01% 425
2023
Q3
$35.7K Buy
636
+51
+9% +$2.87K ﹤0.01% 400
2023
Q2
$29.5K Buy
585
+121
+26% +$6.44K ﹤0.01% 429
2023
Q1
$25.3K Buy
464
+32
+7% +$1.87K ﹤0.01% 439
2022
Q4
$27K Hold
432
﹤0.01% 418
2022
Q3
$30K Buy
+432
New +$29.8K ﹤0.01% 408

Other funds holding AXNX

MCF Advisors's AXNX Position: Q1 2024 in Review

MCF Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 560 shares — an estimated $34.8K sold.

MCF Advisors first reported a position in AXNX in Q3 2022 and held it in 6 quarters. The position peaked at $35.7K in Q3 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • MCF Advisors reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • MCF Advisors sold 560 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $34.8K.
  • MCF Advisors first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • MCF Advisors's Axonics, Inc. Common Stock position peaked at $35.7K in Q3 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on MCF Advisors's 13F filing for Q1 2024, filed 16 Apr 2024.